相关实验视频

Updated: Jun 6, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

在瘤学中提高抗体选择性的策略

Vincent Blay¹, Atanasio Pandiella²

¹University of California Santa Cruz, Department of Microbiology and Environmental Toxicology, Santa Cruz, CA 95064, USA.

Trends in pharmacological sciences

|November 28, 2024

概括

抗体-药物联合体面临挑战,因为它们在健康细胞上有共同的目标. 本综述探讨了改善选择性向癌症部位输送生物制剂的策略,从而提高治疗安全性和疗效.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
分子工程分子工程分子工程

背景情况:

瘤学中的抗体越来越强大,携带有毒的有效载荷和用于向细胞杀死的效应器功能.
一个重大挑战是,在癌细胞和健康组织上存在向抗原,导致瘤外毒性.
这种非瘤结合可以限制基于抗体的癌症治疗的安全性和治疗潜力.

研究的目的:

审查加强选择性向瘤部位输送生物药物的策略.
探索分子设计和工程进步如何实现更精确的准.
讨论开发可以区分生病和健康组织的治疗方法.

主要方法:

对瘤学选择性生物输送的当前和新兴策略的调查.
分析分子设计和用于治疗开发的工程方面的进展.
审查利用癌症特异性变化和宿主生物基础设施的方法.

主要成果:

识别多种策略,以改善基于抗体的治疗方法的瘤选择性.
通过最近的分子工程进展来证明这些策略的可行性.
突出创造治疗方法的潜力,以区分患病的和健康的组织.

结论:

分子设计的进步使得基于抗体的癌症疗法能够更有选择性地提供.
针对利用癌症特异性变化的向策略对于提高安全性至关重要.
未来的治疗方法旨在利用身体的基础设施来区分健康和患病的组织,最大限度地提高疗效,最大限度地降低毒性.

关键词:

抗体是对抗体的重要组成部分.抗体药物合物抗体药物合物抗原是一种抗原.生物学的生物学.癌症癌症癌症癌症癌症多种多样性的特征.瘤微环境是一个微环境.

更多相关视频

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...